2008
DOI: 10.1021/ja803221c
|View full text |Cite
|
Sign up to set email alerts
|

Kinetics of Folding and Binding of an Intrinsically Disordered Protein: The Inhibitor of Yeast Aspartic Proteinase YPrA

Abstract: The 68 residue peptide IA 3 is an intrinsically unstructured protein that serves as an endogenous inhibitor of the yeast aspartic proteinase A (YPrA). Although unstructured in free solution, IA 3 forms an N-terminal alpha helix as it binds to YPrA, leading to subnanomolar inhibition of the protease. Equilibrium structural and inhibition studies provide little insight into the mechanism and kinetics of the coupled folding and binding interaction. We have used laser temperature jump spectroscopy to study the kin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

10
49
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(59 citation statements)
references
References 47 publications
10
49
0
Order By: Relevance
“…Interestingly, the p53 peptide does not appear to be an unusual case, and evidence has recently accumulated to suggest that induced folding is likely prevalent in IDPprotein interactions 5,22 . Induced folding has been consistently observed in mechanistic studies of IDP interaction from experiments [23][24][25] and simulations [26][27][28][29][30] 38 , the p160 steroid receptor co-activator ACTR 39 , the steroid receptor co-activator 1 (SRC1) 40 , and the interferon regulatory factor 3 (IRF3) 41 , respectively. In these complexes, NCBD adopts two distinct folds, which mainly differ in the tertiary packing of three similar helices.…”
Section: Introductionmentioning
confidence: 79%
“…Interestingly, the p53 peptide does not appear to be an unusual case, and evidence has recently accumulated to suggest that induced folding is likely prevalent in IDPprotein interactions 5,22 . Induced folding has been consistently observed in mechanistic studies of IDP interaction from experiments [23][24][25] and simulations [26][27][28][29][30] 38 , the p160 steroid receptor co-activator ACTR 39 , the steroid receptor co-activator 1 (SRC1) 40 , and the interferon regulatory factor 3 (IRF3) 41 , respectively. In these complexes, NCBD adopts two distinct folds, which mainly differ in the tertiary packing of three similar helices.…”
Section: Introductionmentioning
confidence: 79%
“…Even when a protein is stably folded in the absence of ligand, binding always enhances stability except in the unlikely event that the binding affinity of the unfolded protein is equal to or higher than that of the folded form. The mechanism by which these coupled folding and binding reactions take place has stimulated much recent interest (29)(30)(31)(32)(33)(34)(35)(36). Kinetically speaking, the key question is: which occurs first, folding or binding?…”
Section: Resultsmentioning
confidence: 99%
“…Several recent studies have sought to determine the order of steps in sequential folding/binding reactions (8,29,32,33,36). The experiments require transient detection of the folding reaction in the presence of various concentrations of ligand (33).…”
Section: Resultsmentioning
confidence: 99%
“…IA 3 is a 68 amino acid protein that is unstructured in solution and is a potent inhibitor of yeast aspartic proteinase A (YPRA) [60]. IA 3 undergoes an unstructured to α-helical conformation transition upon binding to YPRA, or in the presence of a high content of TFE in the solution [61]. To obtain an EPR signal, residue E10 at the N-termini of IA 3 was mutated to cysteine and subsequently labeled with an IAP spin label (P1).…”
Section: Structural Transitions In Intrinsically Disordered Proteinsmentioning
confidence: 99%